Results 41 to 50 of about 232,178 (355)

Post-Partum Pituitary Insufficiency and Livedo Reticularis Presenting a Diagnostic Challenge in a Resource Limited Setting in Tanzania: A Case Report, Clinical Discussion and Brief Review of Existing Literature. [PDF]

, 2012
Pituitary disorders following pregnancy are an important yet under reported clinical entity in the developing world. Conversely, post partum panhypopituitarism has a more devastating impact on women in such settings due to high fertility rates, poor ...
A Cénac, A Gutenberg, A Lecube, AH Zargar, C Ajith, D Castle, EH Sidibe, EM Tan, F Bakiri, Faheem G Sheriff, GK Leung, H Raff, HC Lee, J Honegger, JD Ji, JR Ouma, Kajiru G Kilonzo, ME Molitch, N Tubridy, P Caturegli, R Golden, R Goswami, RA Kristof, S Diederich, William P Howlett, Y Ozawa, Z Karaca, ZA Erkut   +27 more
core   +3 more sources

European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

Molecular Oncology, EarlyView.
The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations regarding the use of hormone replacement therapy (HRT), which is positioned as recommendation number 13 of the ECAC5.
Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes‐Zoutendijk, Carlijn van der Aalst, Carlos Canelo‐Aybar, Fiorella Karina Fernández‐Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp‐Vogelaar, Andrea DeCensi   +18 more
wiley   +1 more source

The effects of hormone replacement therapy on mammographic density among postmenopausal women in Hospital Raja Perempuan Zainab Ii, Kota Bharu, Kelantan. [PDF]

, 2011
Introduction Hormone replacement therapy (HRT) is commonly prescribed to postmenopausal women to improve their postmenopausal symptoms. Postmenopausal hormone use is associated with increase in mammographic density and increased incidence of breast pain.
Kamaravel, Shanti
core  

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report

Journal of Medical Case Reports, 2009
Introduction The improved survival of children with brain tumors has increased concerns about treatment-related sequelae. Growth hormone deficiency is frequently observed after craniospinal irradiation for medulloblastoma.
Biassoni Veronica, Pallotti Federica, Spreafico Filippo, Seregni Ettore, Gandola Lorenza, Martinetti Antonella, Bombardieri Emilio, Massimino Maura   +7 more
doaj   +1 more source

Pathogenic Neurofibromatosis type 1 gene variants in tumors of non‐NF1 patients and role of R1276

FEBS Open Bio, EarlyView.
Somatic variants of the neurofibromatosis type 1 (NF1) gene occur across neoplasms without clinical manifestation of the disease NF1. We identified emerging somatic pathogenic NF1 variants and hotspots, for example, at the arginine finger 1276. Those missense variants provide fundamental information about neurofibromin's role in cancer.
Mareike Selig, Swanhild Lohse, Sara Elahi, Nils Hartmann, Stefanie Deckert, Shutian Si, Alexander Desuki, Anja Harder   +7 more
wiley   +1 more source

Adrenal function testing following hormone therapy for infantile spasms: case series and review of literature

Frontiers in Neurology, 2015
Prednisolone and adrenocorticotropic hormone (ACTH) are hormone therapies for infantile spasms. There is limited data on the occurrence of decreased adrenal reserve or signs of clinical adrenal insufficiency after hormone therapy. This is a retrospective
John R Mytinger, Sasigarn A Bowden
doaj   +1 more source

Decision aids for people facing health treatment or screening decisions (Review) [PDF]

, 2009
Background Decision aids prepare people to participate in ’close call’ decisions that involve weighing benefits, harms, and scientific uncertainty. Objectives To conduct a systematic review of randomised controlled trials (RCTs) evaluating the efficacy ...
Adab, Armstrong, Auvinen, Auvinen, Barry, Bastian, Bekker, Bekker, Bekker, Bernstein, Briss, Brown, Brundage, Chadwick, Charles, Chewning, Clancy, Colella, Coulter, Crang-Svalenius, Davison, Davison, Deber, Deber, Degner, Deschamps, Deyo, Dodin, Dolan, Dunn, Elwyn, Emmett, Ende, Entwistle, Flood, Frosch, Frosch, Gafni, Gattellari, Gattellari, Godlee, Goel, Graham, Gravel, Green, Green, Green, Green, Greenfield, Gruppen, Gruppen, Hays, Healton, Herrera, Hewison, Hickish, Hochlehnert, Holloway, Holmes-Rovner, Hunt, Hunter, Hunter, Jadad, Johnson, Jorm, Kennedy, LaCroix, Lalonde, Laupacis, Lazcano Ponce, Legare, Lerman, Leung, Lewis, Llewellyn-Thomas, Maisels, Makoul, Man-Son-Hing, Manns, Markham, Martin, Maslin, Maslin, Mazur, McAlister, McBride, McGinley, McInerney-Leo, Michie, Miller, Molenaar, Molenaar, Montgomery, Morgan, Mulley, Mulley, Murray, Murray, Myers, Myers, Nagle, Newton, O'Cathain, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, O'Connor, Oakley, Partin, Pearson, Peele, Phelan, Phillips, Pignone, Proctor, Radloff, Ratliff, Rimer, Rimer, Roland, Roosmalen, Roosmalen, Rostom, Rothert, Rothert, Rovner, Ruland, Ryser, Schapira, Schwartz, Sepucha, Sheridan, Shorten, Sorenson, Spielberger, Stacey, Steiner, Stewart, Street, Street, Tabak, Thomson, Thornton, Valdez, Volk, Volk, Vuorma, Vuorma, Wagner, Wallston, Wang, Whelan, Whelan, Whitney, Willemsen, Wolf, Wolf, Wolf, Wong, Wroe, Zapka   +170 more
core   +3 more sources

Roles of Hormone Replacement Therapy and Menopause on Osteoarthritis and Cardiovascular Disease Outcomes: A Narrative Review [PDF]

, 2022
Yixue Mei, Jennifer S. Williams, Erin K. Webb, Alison K. Shea, Maureen J. MacDonald, Baraa K. Al‐Khazraji   +5 more
openalex   +1 more source

Hormone replacement therapy and the endometrium [PDF]

Journal of Clinical Pathology, 2001
Modern hormone replacement therapy (HRT) regimens contain oestrogen and progestogen, given either in a cyclical or continuous combined manner. Most endometrial biopsies from women on sequential HRT show weak secretory features. Approximately 15% show proliferative activity, although this figure may be less if more than nine days of progestogen is given
K M, Feeley, M, Wells
openaire   +2 more sources